Biotech Values

[genisi]

Meanwhile, I saw a piece by Yoram Gabizon in an Israeli paper about a survey conducted by Oppenheimer in which 26 neurologists treating more than 100 MS patients were asked how Gilenia will change treatment paradigm. I'm too tired to translate now and hopefully there will be an English version tomorrow in http://www.haaretz.com/